Hynion AS (HYN) - Net Assets

Latest as of June 2024: Nkr16.46 Million NOK ≈ $1.73 Million USD

Based on the latest financial reports, Hynion AS (HYN) has net assets worth Nkr16.46 Million NOK (≈ $1.73 Million USD) as of June 2024. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Nkr45.55 Million ≈ $4.79 Million USD) and total liabilities (Nkr29.09 Million ≈ $3.06 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of Hynion AS to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Nkr16.46 Million
% of Total Assets	36.14%
Annual Growth Rate	126.64%
5-Year Change	N/A
10-Year Change	N/A
Growth Volatility	345.12

Hynion AS - Net Assets Trend (2019–2023)

This chart illustrates how Hynion AS's net assets have evolved over time, based on quarterly financial data. Also explore Hynion AS assets under control for the complete picture of this company's asset base.

Annual Net Assets for Hynion AS (2019–2023)

The table below shows the annual net assets of Hynion AS from 2019 to 2023. For live valuation and market cap data, see HYN company net worth.

Year	Net Assets	Change
2023-12-31	Nkr25.91 Million ≈ $2.73 Million	-53.49%
2022-12-31	Nkr55.70 Million ≈ $5.86 Million	-1.09%
2021-12-31	Nkr56.32 Million ≈ $5.93 Million	+705.62%
2020-12-31	Nkr6.99 Million ≈ $735.62K	+611.91%
2019-12-31	Nkr981.96K ≈ $103.33K	--

Equity Component Analysis

This analysis shows how different components contribute to Hynion AS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 300803000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2023)

Component	Amount	Percentage
Common Stock	Nkr535.21K	2.07%
Other Components	Nkr25.37 Million	97.93%
Total Equity	Nkr25.91 Million	100.00%

Hynion AS Competitors by Market Cap

The table below lists competitors of Hynion AS ranked by their market capitalization.

Company	Market Cap
Calidi Biotherapeutics Inc. NYSE MKT:CLDI	$1.55 Million
Golden Cross Resources Ltd AU:GCR	$1.55 Million
Oncternal Therapeutics Inc NASDAQ:ONCT	$1.56 Million
Shirpur Gold Refinery Limited NSE:SHIRPUR-G	$1.56 Million
Uniinfo Telecom Services Limited NSE:UNIINFO	$1.55 Million
CMC Metals Ltd V:CMB	$1.55 Million
Mercia Technologies PLC LSE:MERC	$1.54 Million
Onlineformapro SA PA:MLONL	$1.54 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Hynion AS's equity between the two most recent reporting periods.

Equity Growth Insights

From 2022 to 2023, total equity changed from 55,701,760 to 25,907,871, a change of -29,793,889 (-53.5%).
Net loss of 32,220,080 reduced equity.
Share repurchases of 660,680 reduced equity.
New share issuances of 660,683 increased equity.
Other factors increased equity by 2,426,188.

Equity Change Factors (2022 to 2023)

Factor	Impact	Contribution
Net Income	Nkr-32.22 Million	-124.36%
Share Repurchases	Nkr660.68K	-2.55%
Share Issuances	Nkr660.68K	+2.55%
Other Changes	Nkr2.43 Million	+9.36%
Total Change	Nkr-	-53.49%

Book Value vs Market Value Analysis

This analysis compares Hynion AS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.08x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 1.48x to 0.08x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2019-12-31	Nkr0.01	Nkr0.02	x
2020-12-31	Nkr0.13	Nkr0.02	x
2021-12-31	Nkr1.01	Nkr0.02	x
2022-12-31	Nkr0.53	Nkr0.02	x
2023-12-31	Nkr0.24	Nkr0.02	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Hynion AS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -124.36%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -695.68%
• Asset Turnover: 0.13x
• Equity Multiplier: 1.38x
Recent ROE (-124.36%) is below the historical average (-120.05%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2019	-306.33%	-1350.83%	0.13x	1.71x	Nkr-3.11 Million
2020	-87.31%	-713.99%	0.11x	1.16x	Nkr-6.80 Million
2021	-29.84%	-975.79%	0.03x	1.09x	Nkr-22.44 Million
2022	-52.41%	-702.37%	0.06x	1.26x	Nkr-34.76 Million
2023	-124.36%	-695.68%	0.13x	1.38x	Nkr-34.81 Million

Industry Comparison

This section compares Hynion AS's net assets metrics with peer companies in the Specialty Retail industry.

Industry Context

Industry: Specialty Retail
Average net assets among peers: $574,362,667
Average return on equity (ROE) among peers: 15.28%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Hynion AS (HYN)	Nkr16.46 Million	-306.33%	1.77x	$1.55 Million
Elektroimportoren As (ELIMP)	$274.18 Million	35.47%	2.99x	$82.56 Million
Kid ASA (KID)	$460.73 Million	6.57%	2.84x	$563.71 Million
XXL ASA (XXL)	$988.18 Million	3.80%	3.18x	$73.19 Million

About Hynion AS

OL:HYN Norway Specialty Retail

Market Cap

$1.55 Million

Nkr14.71 Million NOK

Market Cap Rank

#29905 Global

#271 in Norway

Share Price

Nkr0.02

Change (1 day)

+0.00%

52-Week Range

Nkr0.02 - Nkr0.30

All Time High

Nkr7.60